Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  semustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 124 for your search:
Start Over
Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-784651
Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8380
Phase II/III Chemotherapy with FAMe (5-FU/ADR/MeCCNU) with vs without Abdominal Radiotherapy for Unresectable or Local Residual Stage III/IV Gastric Carcinoma (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-804151, NCCTG-804151
Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-834151, MAYO-834151, NCCTG-83-41-51
Phase II/III Combination Chemotherapy with MeFA (MeCCNU/5-FU/ADR) vs FA (ADR/5-FU) for Advanced Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: EORTC-40791
Phase II - III Study of Chemotherapy with MeCCNU, SZC/CTX and SZC/5-FU for Advanced Unresectable Pancreatic Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2272, MAYO-706013
Phase II/III Chemotherapy with Combinations of MeCCNU, MITO, ADR and 5-FU for Advanced Measurable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2277
Master Protocol for Phase II-III Chemotherapy for Pancreatic Carcinoma --- PALA vs SAM (STZ/ADR/MeCCNU)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2279
Phase II-III Study of Chemotherapy with ADR or 5-FU/MeCCNU or 5-FU/Mitomycin C for Advanced Gastric Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3274, MAYO-706018
Phase II and III Chemotherapy with 5-FU, CTX, TG, MeCCNU and TGDR for Advanced Colon and Rectal Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4273
Adriamycin Chemotherapy versus 5-FU/MeCCNU/ADR or 5-FU/MITO/ARA-C for Advanced Gastric Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8375
Phase II-III Study with 5-FU/ICRF-159/MeCCNU, 5-FU/ADR with or without MITO or MeCCNU, and 5-FU/MeCCNU for Unresectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376, MAYO-764101
Phase II-III Combination Chemotherapy with 5-FU/ADR with or without MeCCNU or MITO for Unresectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376R
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-764802
Phase III Chemotherapy with MOF (MeCCNU/VCR/5-FU) vs MOF-STREP (MOF plus SZC) for Advanced, Measurable Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-024-235, MSKCC-7814
Phase III Chemotherapy with Methyl CCNU and Radiotherapy Versus Radiotherapy Plus BCNU for Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: BTSG-7201
Phase III Chemotherapy with VCR/MeCCNU/5-FU for Carcinoma of the Colon in Children
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: SJCRH-GIC-1
Phase III Chemotherapy with 5-FU vs 5-FU/MeCCNU for Colorectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7302
Phase III Radiotherapy and Chemotherapy with 5-FU/MeCCNU and Testolactone for Localized Adenocarcinoma of the Pancreas
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7509
Phase III Chemotherapy with 5-FU/MeCCNU with or without Oral BCG Immunotherapy for Locally Advanced Adenocarcinoma of the Large Bowel
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7510
Phase III Chemotherapy with MOF-Strep (MeCCNU/VCR/5-FU/SZC) vs 5-FU/HU for Dukes C/D or Recurrent Advanced Colorectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2281
Phase III Combination Chemotherapy with MOF (MeCCNU/VCR/5-FU) plus Streptozotocin for Metastatic Carcinoma of the Large Bowel and Rectum
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7715R
Phase III MOF-STREP (MeCCNU/VCR/5-FU/STZ) vs 5-FU Alone as Adjuvant Chemotherapy for Dukes Stage B2/C Colorectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D81-024-368
Phase III Adjuvant Chemotherapy with 5-FU/MeCCNU vs 5-FU/MeCCNU/MITO vs No Chemotherapy After Surgery and Radiotherapy for Dukes B2/C Rectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-032-559
Phase III Immunotherapy with Neuraminidase-Treated Melanoma Cells and BCG vs BCG Alone vs Chemotherapy with MeCCNU for Stage I/II Operable Melanoma (Summary Last Modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: NCI-76-C-151, NCI-IB-2, NCI-T83-1160N, T83-1160
Start Over